反芻動物用ワクチン市場 - 世界の産業規模、シェア、動向、機会、予測、2018年～2028年セグメント：動物タイプ別、ワクチンタイプ別、適応症別、投与経路別、地域別、競合

反芻動物用ワクチンの世界市場は2022年に33億2,000万米ドルと評価され、2028年までのCAGRは5.25%で、予測期間中に目覚ましい成長を遂げると予測されています。

畜産は、世界中で安定した食糧供給と経済的幸福を確保する上で重要な役割を果たしています。様々な種の中でも、ウシ、ヒツジ、ヤギなどの反芻動物は、肉、ミルク、その他の製品の重要な供給源です。これらの家畜の健康と生産性を維持するため、反芻動物用ワクチンは様々な疾病を予防・制御するための不可欠なツールとなっています。反芻動物用ワクチンの世界市場は、家畜の健康への関心の高まり、畜産物への需要の高まり、ワクチン開発における技術進歩などを背景に、大きな成長を遂げています。

反芻家畜は、ウイルス性、細菌性など様々な疾病にかかりやすく、農家にとっては経済的損失、消費者にとっては食糧不足につながります。反芻動物用ワクチンは、こうした疾病の予防と制御に不可欠です。これらのワクチンにはいくつかの重要な利点があります。反芻動物用ワクチンは、口蹄疫、ブルセラ症、牛ウイルス性下痢症などの一般的な病気から家畜を守るように設計されています。ワクチン接種は、これらの病気の発生と蔓延を抑え、畜産業の経済的損失を防ぐのに役立ちます。健康な家畜は生産性が高いです。ワクチン接種は反芻動物の成長率、繁殖率、乳量を改善し、農業生産性の向上につながります。健康な家畜は農業による環境への影響を軽減します。ワクチンは、生態系や人間の健康に影響を与える抗生物質やその他の医薬品の必要性を最小限に抑える役割を果たします。多くの農家にとって、家畜は主な収入源です。ワクチン接種を通じて家畜の健康を守ることは、経済の持続可能性を確保し、農村部の貧困を緩和することにつながります。

反芻動物用ワクチンの世界市場は、いくつかの主な要因によって着実な成長を遂げています。世界人口の増加により、肉、ミルク、その他の畜産物に対する需要が増加しています。このため、より健康で生産性の高い家畜へのニーズが高まっており、反芻動物用ワクチンはその実現に役立っています。バイオテクノロジーとゲノミクスの進歩は、より効果的で安全なワクチンの開発につながりました。サブユニットワクチンやDNAワクチンなどの新しいワクチン技術は、市場の成長に貢献しています。世界各国の政府は、食糧安全保障と農村開発における家畜衛生の重要性を認識しています。多くの国が疾病の蔓延を抑制するためにワクチン接種プログラムや規制を実施しており、反芻動物ワクチン市場を後押ししています。民間部門も公的部門も、新しく改良されたワクチンを生み出すための研究開発に投資しています。これが技術革新を促し、ワクチンの有効性を高めています。

主な市場促進要因

世界人口と食糧需要の増加が反芻動物用ワクチンの世界市場を牽引

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 反芻動物用ワクチンの世界市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 動物タイプ別（ウシ、ヒツジ、ヤギ）
  • ワクチンタイプ別（弱毒生ワクチン、不活化ワクチン、その他）
  • 適応症別（BVD感染症、牛呼吸器疾患（BRD）、レプトスピラ症、クロストリジウム病、下痢/糟糠病、FMD、その他）
  • 投与経路別（注射剤、経鼻剤）
  • 地域別
  • 企業別（2022年）
• 市場マップ
  • 動物タイプ別
  • ワクチンタイプ別
  • 適応症別
  • 投与経路別
  • 地域別

第5章 アジア太平洋の反芻動物用ワクチン市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 動物タイプ別
  • ワクチンタイプ別
  • 適応症別
  • 投与経路別
  • 国別
• アジア太平洋：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の反芻動物ワクチン市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 動物タイプ別
  • ワクチンタイプ別
  • 適応症別
  • 投与経路別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の反芻動物ワクチン市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 動物タイプ別
  • ワクチンタイプ別
  • 適応症別
  • 投与経路別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の反芻動物ワクチン市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 動物タイプ別
  • ワクチンタイプ別
  • 適応症別
  • 投与経路別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカの反芻動物ワクチン市場の展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 動物タイプ別
  • ワクチンタイプ別
  • 適応症別
  • 投与経路別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 反芻動物用ワクチンの世界市場SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Boehringer Ingelheim International GmbH
• Zoetis Services LLC
• Vaxxinova International BV
• Merck & Co., Inc.
• Bimeda Animal Health Ltd.
• Indian Immunologicals Ltd.
• Elanco Animal Health Incorporated
• Virbac
• Ceva Sante Animale
• CZ Vaccines S.A.U.（Zendal Group）

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Ruminant Vaccines Market was valued at USD 3.32 Billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.25% through 2028. Livestock farming plays a crucial role in ensuring a stable food supply and economic well-being across the world. Among the various species, ruminants such as cattle, sheep, and goats are essential sources of meat, milk, and other products. To maintain the health and productivity of these animals, ruminant vaccines have become indispensable tools for preventing and controlling various diseases. The global ruminant vaccines market is witnessing significant growth, driven by an increased focus on livestock health, a growing demand for livestock products, and technological advancements in vaccine development.

Ruminant livestock are susceptible to a wide range of diseases, both viral and bacterial, which can result in economic losses for farmers and food shortages for consumers. Ruminant vaccines are essential for preventing and controlling these diseases. These vaccines offer several key benefits. Ruminant vaccines are designed to protect animals from common diseases like foot-and-mouth disease, brucellosis, bovine viral diarrhea, and more. Vaccination helps reduce the incidence and spread of these diseases, preventing economic losses in the livestock industry. Healthy animals are more productive. Vaccination can improve the growth rates, reproduction rates, and milk yields of ruminants, leading to increased agricultural productivity. Healthy livestock help reduce the environmental impact of farming. Vaccines play a role in minimizing the need for antibiotics and other pharmaceuticals, which can have ecological and human health consequences. For many farmers, livestock is a primary source of income. Protecting the health of their animals through vaccination ensures economic sustainability and helps alleviate poverty in rural areas.

The global ruminant vaccines market is experiencing steady growth due to several key factors. The global population is growing, leading to an increased demand for meat, milk, and other livestock products. This drives the need for healthier and more productive animals, which ruminant vaccines help achieve. Advances in biotechnology and genomics have led to the development of more effective and safer vaccines. New vaccine technologies, such as subunit vaccines and DNA vaccines, are contributing to market growth. Governments worldwide recognize the importance of livestock health for food security and rural development. Many nations have implemented vaccination programs and regulations to control the spread of diseases, boosting the ruminant vaccine market. Both private and public sectors are investing in research and development to create new and improved vaccines. This encourages innovation and enhances the efficacy of vaccines.

Key Market Drivers

Increasing Global Population and Food Demand is Driving the Global Ruminant Vaccines Market

The world's population is on a continuous upward trajectory, and with it, the demand for food has surged to unprecedented levels. This surge in global food demand has put pressure on the agriculture and livestock industries to produce more efficiently, sustainably, and safely. Ruminants, such as cattle, sheep, and goats, play a vital role in global food production, providing meat, milk, and wool to billions of people worldwide. To ensure the health and productivity of these ruminant populations, vaccination has become an integral part of modern livestock management. In response to the growing challenges associated with raising healthy ruminant populations, the global ruminant vaccines market has seen remarkable growth. As per the Worldometer, the world's population surpassed 7.8 billion in 2021 and is expected to continue growing, albeit at a slower pace. This increase in population directly translates to an increase in the demand for food. As people strive to improve their living standards and diets, the demand for animal-based products like meat and dairy has skyrocketed. Ruminants are essential in meeting this demand, contributing to nearly 80% of the world's meat production and a significant portion of the global milk supply. Raising ruminants comes with its set of challenges, including the risk of diseases that can lead to decreased productivity, food safety concerns, and increased costs for farmers. Some of the most common diseases in ruminants, like foot-and-mouth disease, bovine respiratory syncytial virus, and bluetongue, can cause significant economic losses and even result in culling entire herds. In this context, vaccines have emerged as a vital tool in preventing and controlling these diseases. Ruminant vaccines are crucial for maintaining the health and well-being of these animals. They help prevent a wide range of diseases, reduce the need for antibiotics, and promote sustainable farming practices. Vaccines not only protect the animals but also safeguard the food supply chain by ensuring that meat and dairy products meet safety and quality standards. The ruminant vaccines market has seen significant advancements in recent years, with the development of more effective and efficient vaccines. Innovative vaccine delivery methods, such as DNA vaccines and vectored vaccines, are being used to enhance the immune response of ruminants, making them more resilient to diseases. Furthermore, advancements in biotechnology and genomics have enabled the development of tailored vaccines that can address specific regional challenges.

Many governments and international organizations are recognizing the importance of livestock health for food security and economic stability. This has led to increased investment in livestock health programs and vaccination campaigns, further boosting the global ruminant vaccines market. Sustainable livestock farming practices are essential in an era of climate change and environmental concerns. Ruminant vaccines play a role in reducing the need for antibiotics and the environmental footprint of livestock farming. Healthy animals produce food more efficiently, with lower resource consumption and fewer emissions, making vaccines a critical component of sustainable agriculture.

Expanding Veterinary Care and Awareness is Driving the Global Ruminant Vaccines Market

The global ruminant vaccines market is witnessing a significant surge in growth, driven by the expansion of veterinary care and a growing awareness of the importance of protecting ruminant animals, including cattle, sheep, and goats, against various diseases. Ruminants play a crucial role in the global food supply chain, making their health a matter of paramount importance. Vaccines have emerged as a powerful tool to safeguard these animals, reduce economic losses, and ensure food security. Vaccines have long been established as a preventive measure to protect ruminants against a range of diseases. Ruminant vaccines work by stimulating the animal's immune system to produce an immune response without causing the actual disease. By administering vaccines to ruminants, veterinarians can significantly reduce the risk of disease outbreaks, leading to healthier animals and more reliable food production.

One of the primary drivers of the ruminant vaccine market's growth is the expansion of veterinary care in both developed and developing countries. As more regions invest in veterinary infrastructure and healthcare services, there is an increased demand for vaccines to protect ruminant populations. Recent outbreaks of diseases such as foot-and-mouth disease and bovine tuberculosis have raised awareness of the economic consequences of ruminant diseases. Governments and farmers are increasingly investing in vaccination programs as a cost-effective way to mitigate these risks. The importance of disease prevention through vaccination is being increasingly recognized by farmers. They understand that preventing diseases is not only more humane but also more economically viable than treating them after an outbreak. This awareness is driving demand for vaccines. Advances in biotechnology and vaccine development have led to more effective and targeted ruminant vaccines. These innovations have increased the acceptance and utilization of vaccines within the agricultural sector. Many governments and international organizations are providing support for vaccination programs, both through subsidies and regulatory mandates, further fuelling the growth of the ruminant vaccine market.

Key Market Challenges

Disease Variability

One of the primary challenges faced by the global ruminant vaccines market is the vast variability of diseases that affect ruminant animals. These diseases can vary significantly in terms of their geographic prevalence, virulence, and strain diversity. Developing vaccines that are effective against multiple strains or adapting vaccines to local disease strains can be a daunting task. This challenge requires ongoing research and development to keep pace with emerging diseases and evolving pathogens.

Regulatory Hurdles

The ruminant vaccines market is subject to strict regulations and compliance requirements, which can vary from one region to another. Meeting these regulatory requirements can be time-consuming and expensive, as manufacturers must conduct rigorous clinical trials and adhere to stringent safety and efficacy standards. These regulations can pose a significant barrier to the development and distribution of vaccines, particularly for smaller companies and startups.

Vaccine Distribution and Access

Ensuring the distribution of ruminant vaccines to remote or economically disadvantaged regions can be a daunting task. Many small-scale livestock farmers in developing countries lack access to vaccines due to infrastructure limitations, including inadequate cold storage facilities and distribution networks. Bridging this gap to provide equal access to vaccines for all farmers remains a significant challenge.

Cost of Production

The cost of producing ruminant vaccines is relatively high due to the complex and delicate processes involved, including the need for sterile environments and the production of high-quality antigens. The economics of vaccine production can make it unattractive for manufacturers, especially in cases where the demand for vaccines is limited, as is often the case for diseases with sporadic outbreaks.

Vaccine Efficacy and Safety

Ensuring the efficacy and safety of ruminant vaccines is crucial to their adoption and success. Developing vaccines that provide long-lasting protection, are safe for the animals, and do not interfere with the quality of livestock products (e.g., meat and milk) is a challenging process. Additionally, vaccine efficacy can vary from one region to another due to differences in disease strains and environmental factors.

Public Perception and Misinformation

Public perception and misinformation regarding vaccines can also impact the ruminant vaccines market. In some regions, there is a lack of awareness about the benefits of vaccination, and misconceptions about vaccine safety may discourage farmers from using them. Overcoming these issues requires effective education and outreach programs.

Climate Change and Emerging Diseases

Climate change can have a significant impact on the emergence and spread of diseases that affect ruminants. As temperature and precipitation patterns change, the geographic distribution of diseases may shift, making it challenging to predict and prepare for disease outbreaks. This necessitates continuous monitoring and adaptation of vaccine strategies.

Key Market Trends

Technological Advancements

In recent years, the global ruminant vaccines market has witnessed substantial growth, and this trend is primarily attributed to the significant advancements in technology. Ruminants, such as cattle, sheep, and goats, play a crucial role in the agricultural sector, providing meat, milk, and other essential products. However, these animals are also susceptible to various diseases, which can have a significant economic impact on the livestock industry. To combat this, there has been a surge in the development of advanced ruminant vaccines. Ruminants are prone to numerous infectious diseases, including foot-and-mouth disease, brucellosis, and bovine respiratory diseases, which can lead to reduced productivity, increased mortality rates, and economic losses for farmers and the livestock industry as a whole. Vaccination has proven to be an effective and sustainable strategy to prevent and control these diseases. Traditionally, these vaccines were produced using conventional methods, but with the advent of modern technology, the development, production, and distribution of ruminant vaccines have been revolutionized.

One of the most significant technological advancements in recent years is the use of genomics to design vaccines. Understanding the genetic makeup of pathogens and ruminants has enabled the development of more precise and effective vaccines. Researchers can now identify the genes responsible for immunity and target them directly, resulting in more potent vaccines with fewer side effects. The application of biotechnology, including recombinant DNA technology, has allowed for the development of subunit vaccines and the production of specific antigens. These vaccines are not only safer but also highly effective, targeting the disease-causing agents directly. The COVID-19 pandemic has popularized mRNA vaccine technology, which can be applied to the development of ruminant vaccines. This approach offers rapid vaccine development and improved efficacy against a range of diseases, as seen with the development of Pfizer and Moderna vaccines. Nanoparticles and nanoemulsions are being used to enhance the delivery of vaccines, improving their stability and increasing their efficacy.

Recombinant technology allows for the production of vaccines in cell cultures rather than traditional methods like egg-based or live-attenuated vaccines. This results in faster vaccine development and improved safety. Techniques like synthetic biology enable the creation of customized vaccines and can accelerate vaccine development in response to emerging diseases or evolving pathogens. Advanced formulations, such as liposomal or virus-like particle (VLP) vaccines, improve the stability of vaccines and their capacity to stimulate an immune response. Automated screening and characterization of vaccine candidates have increased the efficiency of vaccine development and quality control.

Technological advancements have also transformed vaccine distribution and monitoring. With the help of satellite technology and geographical information systems (GIS), vaccines can be efficiently distributed, and the spread of diseases can be tracked in real time. Furthermore, digital platforms and mobile applications have made it easier for farmers and veterinarians to manage vaccination schedules and monitor animal health.

Segmental Insights

Animal Type Insights

Based on the category of Animal Type, Cattle emerged as the dominant player in the global market for Ruminant Vaccines in 2022. Cattle are at the heart of global agriculture, serving as one of the most valuable assets for farmers and the backbone of the food industry. They provide meat, milk, leather, and other byproducts, contributing to the world's food security and economy. The sheer number of cattle globally, with an estimated 1.5 billion in 2021, surpasses that of any other ruminant species. This makes cattle a central focal point in the ruminant vaccines market. Cattle are economically indispensable, contributing significantly to the agriculture sector. The meat, dairy, and leather industries rely heavily on the health and productivity of cattle. As such, a healthy cattle population is a primary concern for governments and farmers worldwide. This drives the demand for cattle vaccines. Cattle are found in almost every corner of the world. They adapt well to various climates and ecosystems, making them prevalent on every continent. This global distribution results in a consistent demand for cattle vaccines in different regions. Cattle are susceptible to a wide range of diseases, some of which can be highly contagious and devastating to livestock populations. Controlling and preventing these diseases is crucial for maintaining the health of cattle herds and preventing economic losses. Vaccination is one of the most effective ways to achieve this. Cattle and cattle products are frequently traded between countries. To ensure international trade is smooth and that disease outbreaks do not disrupt these transactions, vaccination is crucial. This has further fueled the demand for cattle vaccines. Given the significance of cattle in global agriculture, research and innovation in cattle vaccines have been a priority for many pharmaceutical companies. This has led to the development of advanced vaccines specifically designed to protect cattle from a wide array of diseases, further cementing their dominance in the market.

Vaccine Insights

The Modified/ Attenuated Live Vaccines segment is projected to experience rapid growth during the forecast period. Modified live vaccines are a type of vaccine that contains weakened or attenuated forms of the pathogen responsible for the disease. Unlike inactivated vaccines, which use killed pathogens, modified live vaccines use live, but weakened, forms of the pathogen. These vaccines are designed to replicate within the host animal without causing the actual disease. As a result, they stimulate a robust immune response, producing long-lasting protection. Modified live vaccines are highly effective at stimulating a strong and long-lasting immune response. This is because the live pathogens replicate in the host, mimicking a natural infection, and thus generate a comprehensive immune reaction. One of the key advantages of modified live vaccines is their ability to provide rapid immunity. In many cases, animals can develop protection within a few days, compared to inactivated vaccines, which often require multiple doses and weeks to build immunity. Modified live vaccines are often more cost-effective to produce and administer than inactivated vaccines. The lower production costs make them an attractive option for farmers and ranchers, especially in regions with limited resources. Some modified live vaccines offer cross-protection, meaning they can protect against multiple strains or variations of a pathogen. This is particularly important in regions with diverse pathogen populations.

Regional Insights

North America emerged as the dominant player in the global Ruminant Vaccines market in 2022, holding the largest market share in terms of value. North America boasts a robust veterinary infrastructure that supports vaccine research, development, and distribution. This includes world-class research facilities, diagnostic labs, and a network of experienced veterinarians who work closely with livestock producers to implement vaccination programs effectively. The region is home to several leading pharmaceutical and biotechnology companies specializing in animal health, including ruminant vaccines. These companies invest heavily in research and development to create innovative vaccines that address evolving challenges in the livestock industry.

Key Market Players

Boehringer Ingelheim International GmbH

Zoetis Services LLC

Vaxxinova International BV

Merck & Co., Inc.

Bimeda Animal Health Ltd.

Indian Immunologicals Ltd.

Elanco Animal Health Incorporated

Virbac

Ceva Sante Animale

CZ Vaccines S.A.U. (Zendal Group)

Report Scope:

In this report, the Global Ruminant Vaccines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ruminant Vaccines Market, By Animal Type:

• Cattle
• Sheep & Goats

Ruminant Vaccines Market, By Vaccine Type:

• Modified/ Attenuated Live
• Inactivated (Killed)
• Others

Ruminant Vaccines Market, By Vaccines Indication:

• BVD Infection
• Bovine Respiratory Diseases (BRD)
• Leptospirosis Clostridial diseases
• Diarrhea/ Scours
• FMD
• Others

Ruminant Vaccines Market, By Route of Administration:

• Injectable
• Intranasal

Ruminant Vaccines Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Ruminant Vaccines Market.

Available Customizations:

• Global Ruminant Vaccines market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Ruminant Vaccines Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Animal Type (Cattle, Sheep & Goats)
  • 4.2.2. By Vaccine Type (Modified/ Attenuated Live, Inactivated (Killed), Others)
  • 4.2.3. By Vaccines Indication (BVD Infection, Bovine Respiratory Diseases (BRD), Leptospirosis, Clostridial diseases, Diarrhea/ Scours, FMD, Others)
  • 4.2.4. By Route of Administration (Injectable, Intranasal)
  • 4.2.5. By Region
  • 4.2.6. By Company (2022)
• 4.3. Market Map
  • 4.3.1. By Animal Type
  • 4.3.2. By Vaccine Type
  • 4.3.3. By Vaccines Indication
  • 4.3.4. By Route of Administration
  • 4.3.5. By Region

5. Asia Pacific Ruminant Vaccines Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Animal Type
  • 5.2.2. By Vaccine Type
  • 5.2.3. By Vaccines Indication
  • 5.2.4. By Route of Administration
  • 5.2.5. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Ruminant Vaccines Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Animal Type
      • 5.3.1.2.2. By Vaccine Type
      • 5.3.1.2.3. By Vaccines Indication
      • 5.3.1.2.4. By Route of Administration
  • 5.3.2. India Ruminant Vaccines Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Animal Type
      • 5.3.2.2.2. By Vaccine Type
      • 5.3.2.2.3. By Vaccines Indication
      • 5.3.2.2.4. By Route of Administration
  • 5.3.3. Australia Ruminant Vaccines Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Animal Type
      • 5.3.3.2.2. By Vaccine Type
      • 5.3.3.2.3. By Vaccines Indication
      • 5.3.3.2.4. By Route of Administration
  • 5.3.4. Japan Ruminant Vaccines Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Animal Type
      • 5.3.4.2.2. By Vaccine Type
      • 5.3.4.2.3. By Vaccines Indication
      • 5.3.4.2.4. By Route of Administration
  • 5.3.5. South Korea Ruminant Vaccines Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Animal Type
      • 5.3.5.2.2. By Vaccine Type
      • 5.3.5.2.3. By Vaccines Indication
      • 5.3.5.2.4. By Route of Administration

6. Europe Ruminant Vaccines Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Animal Type
  • 6.2.2. By Vaccine Type
  • 6.2.3. By Vaccines Indication
  • 6.2.4. By Route of Administration
  • 6.2.5. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Ruminant Vaccines Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Animal Type
      • 6.3.1.2.2. By Vaccine Type
      • 6.3.1.2.3. By Vaccines Indication
      • 6.3.1.2.4. By Route of Administration
  • 6.3.2. Germany Ruminant Vaccines Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Animal Type
      • 6.3.2.2.2. By Vaccine Type
      • 6.3.2.2.3. By Vaccines Indication
      • 6.3.2.2.4. By Route of Administration
  • 6.3.3. Spain Ruminant Vaccines Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Animal Type
      • 6.3.3.2.2. By Vaccine Type
      • 6.3.3.2.3. By Vaccines Indication
      • 6.3.3.2.4. By Route of Administration
  • 6.3.4. Italy Ruminant Vaccines Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Animal Type
      • 6.3.4.2.2. By Vaccine Type
      • 6.3.4.2.3. By Vaccines Indication
      • 6.3.4.2.4. By Route of Administration
  • 6.3.5. United Kingdom Ruminant Vaccines Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Animal Type
      • 6.3.5.2.2. By Vaccine Type
      • 6.3.5.2.3. By Vaccines Indication
      • 6.3.5.2.4. By Route of Administration

7. North America Ruminant Vaccines Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Animal Type
  • 7.2.2. By Vaccine Type
  • 7.2.3. By Vaccines Indication
  • 7.2.4. By Route of Administration
  • 7.2.5. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Ruminant Vaccines Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Animal Type
      • 7.3.1.2.2. By Vaccine Type
      • 7.3.1.2.3. By Vaccines Indication
      • 7.3.1.2.4. By Route of Administration
  • 7.3.2. Mexico Ruminant Vaccines Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Animal Type
      • 7.3.2.2.2. By Vaccine Type
      • 7.3.2.2.3. By Vaccines Indication
      • 7.3.2.2.4. By Route of Administration
  • 7.3.3. Canada Ruminant Vaccines Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Animal Type
      • 7.3.3.2.2. By Vaccine Type
      • 7.3.3.2.3. By Vaccines Indication
      • 7.3.3.2.4. By Route of Administration

8. South America Ruminant Vaccines Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Animal Type
  • 8.2.2. By Vaccine Type
  • 8.2.3. By Vaccines Indication
  • 8.2.4. By Route of Administration
  • 8.2.5. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Ruminant Vaccines Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Animal Type
      • 8.3.1.2.2. By Vaccine Type
      • 8.3.1.2.3. By Vaccines Indication
      • 8.3.1.2.4. By Route of Administration
  • 8.3.2. Argentina Ruminant Vaccines Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Animal Type
      • 8.3.2.2.2. By Vaccine Type
      • 8.3.2.2.3. By Vaccines Indication
      • 8.3.2.2.4. By Route of Administration
  • 8.3.3. Colombia Ruminant Vaccines Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Animal Type
      • 8.3.3.2.2. By Vaccine Type
      • 8.3.3.2.3. By Vaccines Indication
      • 8.3.3.2.4. By Route of Administration

9. Middle East and Africa Ruminant Vaccines Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Animal Type
  • 9.2.2. By Vaccine Type
  • 9.2.3. By Vaccines Indication
  • 9.2.4. By Route of Administration
  • 9.2.5. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Ruminant Vaccines Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Animal Type
      • 9.3.1.2.2. By Vaccine Type
      • 9.3.1.2.3. By Vaccines Indication
      • 9.3.1.2.4. By Route of Administration
  • 9.3.2. Saudi Arabia Ruminant Vaccines Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Animal Type
      • 9.3.2.2.2. By Vaccine Type
      • 9.3.2.2.3. By Vaccines Indication
      • 9.3.2.2.4. By Route of Administration
  • 9.3.3. UAE Ruminant Vaccines Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Animal Type
      • 9.3.3.2.2. By Vaccine Type
      • 9.3.3.2.3. By Vaccines Indication
      • 9.3.3.2.4. By Route of Administration

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Ruminant Vaccines Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Boehringer Ingelheim International GmbH
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Product & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Zoetis Services LLC
• 14.3. Vaxxinova International BV
• 14.4. Merck & Co., Inc.
• 14.5. Bimeda Animal Health Ltd.
• 14.6. Indian Immunologicals Ltd.
• 14.7. Elanco Animal Health Incorporated
• 14.8. Virbac
• 14.9. Ceva Sante Animale
• 14.10. CZ Vaccines S.A.U. (Zendal Group)

15. Strategic Recommendations

16. About Us & Disclaimer